Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans.
MDR
calcium
copper
iron
magnesium and manganese
magnesium and manganese.MDR
micronutrient
zinc
Journal
Current drug discovery technologies
ISSN: 1875-6220
Titre abrégé: Curr Drug Discov Technol
Pays: United Arab Emirates
ID NLM: 101157212
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
08
2018
revised:
08
01
2019
accepted:
30
01
2019
pubmed:
5
3
2019
medline:
21
9
2021
entrez:
5
3
2019
Statut:
ppublish
Résumé
Fungal infections, particularly of Candida species, which are the commensal organisms of human, are one of the major debilitating diseases in immunocompromised patients. The limited number of antifungal drugs available to treat Candida infections, with the concomitant increasing incidence of multidrug-resistant (MDR) strains, further worsens the therapeutic options. Thus, there is an urgent need for the better understanding of MDR mechanisms, and their reversal, by employing new strategies to increase the efficacy and safety profiles of currently used therapies against the most prevalent human fungal pathogen, Candida albicans. Micronutrient availability during C. albicans infection is regarded as a critical factor that influences the progression and magnitude of the disease. Intracellular pathogens colonize a variety of anatomical locations that are likely to be scarce in micronutrients, as a defense strategy adopted by the host, known as nutritional immunity. Indispensable critical micronutrients are required both by the host and by C. albicans, especially as a cofactor in important metabolic functions. Since these micronutrients are not freely available, C. albicans need to exploit host reservoirs to adapt within the host for survival. The ability of pathogenic organisms, including C. albicans, to sense and adapt to limited micronutrients in the hostile environment is essential for survival and confers the basis of its success as a pathogen. This review describes that micronutrients availability to C. albicans is a key attribute that may be exploited when one considers designing strategies aimed at disrupting MDR in this pathogenic fungi. Here, we discuss recent advances that have been made in our understanding of fungal micronutrient acquisition and explore the probable pathways that may be utilized as targets.
Identifiants
pubmed: 30827249
pii: CDDT-EPUB-96922
doi: 10.2174/1570163816666190227231437
doi:
Substances chimiques
Antifungal Agents
0
Metals
0
Micronutrients
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
415-429Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.